Biodeal Pharmaceuticals acquires Biological E facility, expands into sterile injectables
The manufacturing facility adds 135 million-unit annual capacity, with Carbapenem line now operational and validated under…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Biodeal Pharmaceuticals
Biodeal Pharma raises ₹385 cr growth investment from RMB Capitalworks
Investment validates Biodeal's leadership in specialty pharma manufacturing, strengthens its regulated-market platform, and…
Biodeal Pharmaceuticals concludes successful Piramal Alternatives partnership
Piramal Alternatives announced the successful conclusion of the investment made by its fund, Piramal Structured Credit…
Sharp spike in pharma, healthcare funding in April 2024, touches $332 mn
API Holdings secured the biggest deal ($216 million), followed by La Renon ( $70 million) and Biodeal Pharmaceuticals ($13.2…